查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1210922

霍乱疫苗全球市场规模和预测：按疫苗类型、副产品（Vaxchora、Dukoral、Shanchol、其他产品）、区域分析，2022-2029 年

Global Cholera Vaccines Market Size study & Forecast, by Vaccine Type (Whole cell V. cholerae O1 with Recombinant B-subunit, and Killed Oral O1, and O139), by Product (Vaxchora, Dukoral, Shanchol and Other Products) and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球霍乱疫苗市场价值约为 8650 万美元，预计在 2022-2029 年预测期内将以超过 8.2% 的健康增长率增长。

引起霍乱的霍乱弧菌通过摄入受污染的食物和水传播。 受感染的个体会出现急性水样腹泻，最终导致脱水。 如果不及时治疗，这种情况会导致脱水甚至死亡。 口服免疫疗法已被证明是避免霍乱流行最有效的预防措施。 市场增长是由霍乱高发病率和霍乱控制工作数量增加等关键因素推动的。

由于多种因素，包括公共和私营部门活动增加、霍乱流行率上升以及全球对该病的认识提高，霍乱疫苗市场正在增长。 据世界卫生组织统计，2020年所有国家报告了1.3至140万例霍乱病例，其中非洲17例，亚洲12例，欧洲4例，美洲4例。。 80% 的病例发生在海地、刚果民主共和国、越南、也门、秘鲁、索马里和坦桑尼亚。 然而，疫苗的副作用阻碍了整个 2022-2029 年预测期内的市场增长。

全球霍乱疫苗市场研究考虑的主要区域包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于发病率高、意识增强和有效预防解决方案的可用性，亚太地区有记录以来成为最大的地区。 然而，由于前往霍乱疫情国家的旅行增加以及疫苗接种需求增加，预计北美将成为增长最快的地区。

本研究的目的是阐明近年来各个细分市场和国家/地区的市场规模，并预测未来几年的市场规模。 本报告旨在捕捉被调查国家行业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还包含供利益相关者投资的微观市场潜在机会，以及对主要参与者的竞争格局和产品供应的深入分析。

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年按全球市场和细分划分的市场估计和预测
    • 霍乱疫苗市场：按地区划分，2019-2029 年
    • 霍乱疫苗市场：按疫苗类型分类，2019-2029 年
    • 2019-2029 年各产品的霍乱疫苗市场
  • 主要趋势
  • 调查方法介绍
  • 调查先决条件

第 2 章霍乱疫苗全球市场定义和范围

  • 调查的目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 调查年份
  • 货币兑换率

第三章霍乱疫苗全球市场动态

  • 霍乱疫苗市场影响分析 (2019-2029)
    • 市场驱动因素
      • 霍乱高发
      • 控制霍乱的更多举措
    • 市场挑战
      • 疫苗的副作用
    • 市场机会
      • 提高对霍乱预防医学的认识
      • 全球霍乱疫苗的增加

第 4 章全球霍乱疫苗市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 顶级投资机会
  • 关键成功策略
  • 行业专家的展望
  • 分析师的结论和建议

第 5 章风险评估：COVID-19 的影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球霍乱疫苗市场，按疫苗类型分列

  • 市场概况
  • 全球霍乱疫苗市场：按疫苗类型进行性能潜力分析
  • 世界霍乱疫苗市场，按疫苗类型估算和预测（2019-2029 年）
  • 霍乱疫苗市场细分分析
    • 包含重组 B 亚基的全细胞霍乱弧菌 O1
    • 杀死 O1 和 O139

第 7 章：霍乱疫苗的全球市场：按产品分类

  • 市场概况
  • 全球霍乱疫苗市场：按产品、性能潜力分析
  • 2019-2029 年世界霍乱疫苗市场、按产品估算和预测
  • 霍乱疫苗市场细分分析
    • 巴克斯科拉
    • 双珊瑚
    • 陈哲
    • 其他产品

第 8 章全球霍乱疫苗市场：区域分析

  • 霍乱疫苗市场，按地区划分的市场概况
  • 北美
    • 美国
      • 2019-2029 年按疫苗类型估算和预测
      • 2019-2029 年按产品估算和预测
    • 加拿大
  • 欧洲霍乱疫苗市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲地区
  • 亚太地区霍乱疫苗市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲的霍乱疫苗市场概况
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 世界其他地方

第 9 章衝突信息

  • 顶级市场策略
  • 公司简介
    • 田边三菱製药公司
      • 主要信息
      • 概览
      • 财务信息（取决于数据可用性）
      • 产品概述
      • 近期趋势
    • Takeda Pharmaceutical Co., Ltd.
    • AstraZeneca
    • GlaxoSmithKline plc（GSK）
    • Shantha Biotechnics Private Limited
    • Valneva SE
    • Astellas Pharma, Inc.
    • Emergent BioSolutions, Inc.
    • Pfizer, Inc.
    • Merck & Co., Inc.

第 10 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查属性
  • 调查先决条件

Global Cholera Vaccines Market is valued at approximately USD 86.5 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.2% over the forecast period 2022-2029. Vibrio cholera, which causes cholera, is spread by the intake of contaminated food or water. The infected people experience acute watery diarrhea, which eventually results in dehydration. If this condition is left untreated, the water loss might result in death. In order to avoid cholera epidemics, oral immunization has been found to be the most effective prophylactic measure. The market growth is driven by key players such as high incidence of cholera and rise in the number of initiatives to control cholera

The market for cholera vaccines is expanding as a result of several causes, including rising public and private sector activities, rising cholera prevalence, and increased global awareness of the disease. According to the World Health Organization, there were between 1.3 to 1.4 million cases of cholera reported in 2020 throughout all nations, including 17 in Africa, 12 in Asia, 4 in Europe, and 4 in the Americas. Eighty percent of all cases were in Haiti, the Demographic Republic of the Congo, Vietnam, Yemen, Peru, Somalia, and Tanzania. However, adverse effects of vaccines stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Cholera Vaccines Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific is recorded to be the largest region owing to high incidence rate, growing awareness, and availability of efficient preventive solutions. However, North America is expected to be the fastest growing region due to number of people traveling to countries with sudden outbreaks of cholera is increasing and demand for immunization is growing.

Major market players included in this report are:

Mitsubishi Tanabe Pharma Corporation

Takeda Pharmaceutical Co., Ltd.

AstraZeneca

GlaxoSmithKline plc (GSK)

Shantha Biotechnics Private Limited

Valneva SE

Astellas Pharma, Inc.

Emergent BioSolutions, Inc.

Pfizer, Inc.

Merck & Co., Inc.

Recent Developments in the Market:

  • In May 2022, more than 1.9 million children in Malawi are the target of a cholera immunisation campaign started by the World Health Organization Africa.
  • In June 2022, an oral cholera immunisation programme was started by the Ministry of Health and Partners in the Juba Country of Central Equatoria State. The campaign is a component of a plan of action to stop cholera outbreaks in the identified hotspot region.

Global Cholera Vaccines Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Vaccine type, Product, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Vaxchora

Dukoral

Shanchol

Other Products

By Vaccine Type:

Whole cell V. cholerae O1 with Recombinant B-subunit

Killed Oral O1 and O139

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Cholera Vaccine Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Cholera Vaccine Market, by Vaccine Type, 2019-2029 (USD Million)
    • 1.2.3. Cholera Vaccine Market, by Product, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cholera Vaccine Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cholera Vaccine Market Dynamics

  • 3.1. Cholera Vaccine Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. High incidence of cholera
      • 3.1.1.2. Rise in the number of initiatives to control cholera
    • 3.1.2. Market Challenges
      • 3.1.2.1. Adverse effects of vaccines
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising awareness about cholera preventive care
      • 3.1.3.2. Rise in cholera vaccines across the world

Chapter 4. Global Cholera Vaccine Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Cholera Vaccine Market, by Vaccine Type

  • 6.1. Market Snapshot
  • 6.2. Global Cholera Vaccine Market by Vaccine Type, Performance - Potential Analysis
  • 6.3. Global Cholera Vaccine Market Estimates & Forecasts by Vaccine Type 2019-2029 (USD Million)
  • 6.4. Cholera Vaccine Market, Sub Segment Analysis
    • 6.4.1. Whole cell V. cholerae O1 with Recombinant B-subunit
    • 6.4.2. Killed Oral O1 and O139

Chapter 7. Global Cholera Vaccine Market, by Product

  • 7.1. Market Snapshot
  • 7.2. Global Cholera Vaccine Market by Product, Performance - Potential Analysis
  • 7.3. Global Cholera Vaccine Market Estimates & Forecasts by Product 2019-2029 (USD Million)
  • 7.4. Cholera Vaccine Market, Sub Segment Analysis
    • 7.4.1. Vaxchora
    • 7.4.2. Dukoral
    • 7.4.3. Shanchol
    • 7.4.4. Other Products

Chapter 8. Global Cholera Vaccine Market, Regional Analysis

  • 8.1. Cholera Vaccine Market, Regional Market Snapshot
  • 8.2. North America Cholera Vaccine Market
    • 8.2.1. U.S. Cholera Vaccine Market
      • 8.2.1.1. Vaccine Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Product breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Cholera Vaccine Market
  • 8.3. Europe Cholera Vaccine Market Snapshot
    • 8.3.1. U.K. Cholera Vaccine Market
    • 8.3.2. Germany Cholera Vaccine Market
    • 8.3.3. France Cholera Vaccine Market
    • 8.3.4. Spain Cholera Vaccine Market
    • 8.3.5. Italy Cholera Vaccine Market
    • 8.3.6. Rest of Europe Cholera Vaccine Market
  • 8.4. Asia-Pacific Cholera Vaccine Market Snapshot
    • 8.4.1. China Cholera Vaccine Market
    • 8.4.2. India Cholera Vaccine Market
    • 8.4.3. Japan Cholera Vaccine Market
    • 8.4.4. Australia Cholera Vaccine Market
    • 8.4.5. South Korea Cholera Vaccine Market
    • 8.4.6. Rest of Asia Pacific Cholera Vaccine Market
  • 8.5. Latin America Cholera Vaccine Market Snapshot
    • 8.5.1. Brazil Cholera Vaccine Market
    • 8.5.2. Mexico Cholera Vaccine Market
    • 8.5.3. Rest of Latin America Cholera Vaccine Market
  • 8.6. Rest of The World Cholera Vaccine Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Mitsubishi Tanabe Pharma Corporation
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Takeda Pharmaceutical Co., Ltd.
    • 9.2.3. AstraZeneca
    • 9.2.4. GlaxoSmithKline plc (GSK)
    • 9.2.5. Shantha Biotechnics Private Limited
    • 9.2.6. Valneva SE
    • 9.2.7. Astellas Pharma, Inc.
    • 9.2.8. Emergent BioSolutions, Inc.
    • 9.2.9. Pfizer, Inc.
    • 9.2.10. Merck & Co., Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Cholera Vaccine Market, report scope
  • TABLE 2. Global Cholera Vaccine Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global Cholera Vaccine Market estimates & forecasts by Vaccine Type 2019-2029 (USD Million)
  • TABLE 4. Global Cholera Vaccine Market estimates & forecasts by Product 2019-2029 (USD Million)
  • TABLE 5. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 6. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 7. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. U.S. Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. U.S. Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 17. U.S. Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 18. Canada Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 19. Canada Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 20. Canada Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 21. UK Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 22. UK Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 23. UK Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 24. Germany Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 25. Germany Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 26. Germany Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 27. France Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 28. France Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 29. France Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 30. Italy Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 31. Italy Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 32. Italy Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 33. Spain Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 34. Spain Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 35. Spain Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 36. RoE Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 37. RoE Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 38. RoE Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 39. China Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 40. China Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 41. China Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 42. India Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 43. India Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 44. India Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 45. Japan Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 46. Japan Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 47. Japan Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 48. South Korea Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 49. South Korea Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 50. South Korea Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 51. Australia Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 52. Australia Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 53. Australia Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 54. RoAPAC Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 55. RoAPAC Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 56. RoAPAC Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 57. Brazil Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 58. Brazil Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 59. Brazil Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 60. Mexico Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 61. Mexico Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 62. Mexico Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 63. RoLA Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 64. RoLA Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 65. RoLA Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 66. Row Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 67. Row Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 68. Row Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 69. List of secondary sources, used in the study of global Cholera Vaccine Market
  • TABLE 70. List of primary sources, used in the study of global Cholera Vaccine Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Cholera Vaccine Market, research methodology
  • FIG 2. Global Cholera Vaccine Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Cholera Vaccine Market, key trends 2021
  • FIG 5. Global Cholera Vaccine Market, growth prospects 2022-2029
  • FIG 6. Global Cholera Vaccine Market, porters 5 force model
  • FIG 7. Global Cholera Vaccine Market, pest analysis
  • FIG 8. Global Cholera Vaccine Market, value chain analysis
  • FIG 9. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global Cholera Vaccine Market, regional snapshot 2019 & 2029
  • FIG 15. North America Cholera Vaccine Market 2019 & 2029 (USD Million)
  • FIG 16. Europe Cholera Vaccine Market 2019 & 2029 (USD Million)
  • FIG 17. Asia Pacific Cholera Vaccine Market 2019 & 2029 (USD Million)
  • FIG 18. Latin America Cholera Vaccine Market 2019 & 2029 (USD Million)
  • FIG 19. Global Cholera Vaccine Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable